* Neuronetics Inc STIM.OQ STIM.O is expected to show a
rise in
quarterly revenue when it reports results on May 9.
* The Malvern Pennsylvania-based company is expected to
report a
7.0% increase in revenue to $15.18 million from $14.18 million a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. The company's guidance on March 7 2023, for
the period ended March 31, was for revenue between $15.00
million and $16.00 million.
* Refinitiv's mean analyst estimate for Neuronetics Inc is
for a
loss of 39 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Neuronetics
Inc
is $7, above its last closing price of $2.25.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 -0.35 -0.38 -0.30 Beat 21.3
Sep. 30 2022 -0.42 -0.42 -0.28 Beat 33.5
Jun. 30 2022 -0.41 -0.41 -0.39 Beat 5.3
Mar. 31 2022 -0.40 -0.40 -0.41 Missed -2.6
Dec. -0.31 -0.32 -0.29 Beat 8.2
31 2021
Sep. 30 2021 -0.32 -0.30 -0.31 Missed -2.6
Jun. 30 2021 -0.24 -0.24 -0.29 Missed -20.8
Mar. 31 2021 -0.29 -0.31 -0.31 Met 0
This summary was machine generated May 5 at 18:32 GMT. All
figures in US dollars unless otherwise stated